Terms: = Endocrine gland cancer AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA
84 results:
1. Clinical and genetic analysis of a case of Gitelman syndrome accompanied with Graves disease and adrenocortical adenoma: A case report.
Qiao Y; Zhao J; Wu J; Cao L; Song G; Mao J
Medicine (Baltimore); 2024 Apr; 103(15):e37770. PubMed ID: 38608089
[TBL] [Abstract] [Full Text] [Related]
2. DNMT1/dnmt3a-mediated promoter hypermethylation and transcription activation of ICAM5 augments thyroid carcinoma progression.
Li Z; Ying Y; Zeng X; Liu J; Xie Y; Deng Z; Hu Z; Yang J
Funct Integr Genomics; 2024 Jan; 24(1):12. PubMed ID: 38228798
[TBL] [Abstract] [Full Text] [Related]
3. Evolutionary mode and timing of dissemination of high-grade serous carcinomas.
Sveen A; Johannessen B; Klokkerud SM; Kraggerud SM; Meza-Zepeda LA; Bjørnslett M; Bischof K; Myklebost O; Taskén K; Skotheim RI; Dørum A; Davidson B; Lothe RA
JCI Insight; 2024 Jan; 9(3):. PubMed ID: 38175731
[TBL] [Abstract] [Full Text] [Related]
4. Enhancing wound healing and overcoming cisplatin resistance in ovarian cancer.
Zhang Q; Guo F; Liu H; Hong L
Int Wound J; 2024 Apr; 21(4):e14569. PubMed ID: 38158767
[TBL] [Abstract] [Full Text] [Related]
5. The frequency of mutations in advanced thyroid cancer in Japan: a single-center study.
Toda S; Iwasaki H; Okubo Y; Hayashi H; Kadoya M; Takahashi H; Yokose T; Hiroshima Y; Masudo K
Endocr J; 2024 Jan; 71(1):31-37. PubMed ID: 38044137
[TBL] [Abstract] [Full Text] [Related]
6. miR-29c-3p acts as a tumor promoter by regulating β-catenin signaling through suppressing dnmt3a, TET1 and HBP1 in ovarian carcinoma.
Zhao H; Feng L; Cheng R; Wu M; Bai X; Fan L; Liu Y
Cell Signal; 2024 Jan; 113():110936. PubMed ID: 37925048
[TBL] [Abstract] [Full Text] [Related]
7. DNA hypermethylation driven by DNMT1 and dnmt3a favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma.
Kerdivel G; Amrouche F; Calmejane MA; Carallis F; Hamroune J; Hantel C; Bertherat J; Assié G; Boeva V
Clin Epigenetics; 2023 Aug; 15(1):121. PubMed ID: 37528470
[TBL] [Abstract] [Full Text] [Related]
8. Facility type is associated with improved perioperative and oncologic outcomes after minimally invasive surgery for pancreatic cancer.
Servin-Rojas M; Shafique N; Sell NM; Gamblin TC; Qadan M
HPB (Oxford); 2023 Aug; 25(8):933-940. PubMed ID: 37149486
[TBL] [Abstract] [Full Text] [Related]
9.
Wang K; Gong D; Qiao X; Zheng J
Life Sci Alliance; 2023 Apr; 6(5):. PubMed ID: 37085288
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA KCNQ1OT1 promotes the metastasis of ovarian cancer by increasing the methylation of EIF2B5 promoter.
He SL; Chen YL; Chen QH; Tian Q; Yi SJ
Mol Med; 2022 Sep; 28(1):112. PubMed ID: 36100884
[TBL] [Abstract] [Full Text] [Related]
11. CircPTPRM accelerates malignancy of papillary thyroid cancer via miR-885-5p/dnmt3a axis.
Chen D; Jiang X; Luo H; Hua Q; Zhang F
J Clin Lab Anal; 2022 Oct; 36(10):e24688. PubMed ID: 36098040
[TBL] [Abstract] [Full Text] [Related]
12. Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expression of Cyclin D1 and WEE1, phosphorylates TP53 and reduces cell proliferation in a kinase-dependent manner.
Woods ML; Weiss A; Sokol AM; Graumann J; Boettger T; Richter AM; Schermuly RT; Dammann RH
Cancer Gene Ther; 2022 Dec; 29(12):1975-1987. PubMed ID: 35902728
[TBL] [Abstract] [Full Text] [Related]
13. Downregulation of dnmt3a Attenuates the Warburg Effect, Proliferation, and Invasion via Promoting the Inhibition of miR-603 on HK2 in Ovarian cancer.
Lu J; Zhen S; Tuo X; Chang S; Yang X; Zhou Y; Chen W; Zhao L; Li X
Technol Cancer Res Treat; 2022; 21():15330338221110668. PubMed ID: 35770296
[No Abstract] [Full Text] [Related]
14. Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian cancer.
Weber-Lassalle K; Ernst C; Reuss A; Möllenhoff K; Baumann K; Jackisch C; Hauke J; Dietrich D; Borde J; Park-Simon TW; Hanker L; Prieske K; Schmidt S; Weber-Lassalle N; Pohl-Rescigno E; Kommoss S; Marmé F; Heitz F; Stingl JC; Schmutzler RK; Harter P; Hahnen E
J Natl Cancer Inst; 2022 Apr; 114(4):565-570. PubMed ID: 34963005
[TBL] [Abstract] [Full Text] [Related]
15. Protein phosphatase 2A inactivation induces microsatellite instability, neoantigen production and immune response.
Yen YT; Chien M; Wu PY; Ho CC; Ho CT; Huang KC; Chiang SF; Chao KSC; Chen WT; Hung SC
Nat Commun; 2021 Dec; 12(1):7297. PubMed ID: 34911954
[TBL] [Abstract] [Full Text] [Related]
16. Predictive value of m5C regulatory gene expression in pancreatic adenocarcinoma.
Yu X; Zhang Q; Gao F; Zhang M; Zheng Q; He Y; Guo W
Sci Rep; 2021 Sep; 11(1):17529. PubMed ID: 34471186
[TBL] [Abstract] [Full Text] [Related]
17. A CRISPR-Cas9-Based Near-Infrared Upconversion-Activated DNA Methylation Editing System.
Chi J; Zhao J; Wei S; Li Y; Zhi J; Wang H; Hou X; Hu L; Zheng X; Gao M
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6043-6052. PubMed ID: 33525876
[TBL] [Abstract] [Full Text] [Related]
18. [Ginsenoside 20(S)-Rg3 upregulates tumor suppressor VHL gene expression by suppressing dnmt3a-mediated promoter methylation in ovarian cancer cells].
Wang L; Han X; Zheng X; Zhou Y; Hou H; Chen W; Li X; Zhao L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):100-106. PubMed ID: 33509760
[TBL] [Abstract] [Full Text] [Related]
19. BRCA Methylation Testing Identifies a Subset of Ovarian Carcinomas without Germline Variants That Can Benefit from PARP Inhibitor.
Sahnane N; Carnevali I; Formenti G; Casarin J; Facchi S; Bombelli R; Di Lauro E; Memoli D; Salvati A; Rizzo F; Sessa F; Tibiletti MG
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352687
[TBL] [Abstract] [Full Text] [Related]
20. MassArray analysis of genomic susceptibility variants in ovarian cancer.
Verma S; Sharma I; Sharma V; Bhat A; Shah R; Bhat GR; Sharma B; Bakshi D; Nagpal A; Wakhloo A; Bhat A; Kumar R
Sci Rep; 2020 Dec; 10(1):21101. PubMed ID: 33273524
[TBL] [Abstract] [Full Text] [Related]
[Next]
